Clinical trial
Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate…
NCT00153543 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00153543 |
|---|---|
| Title | Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders |
| Official title | Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Alaska Native Tribal Health Consortium Southcentral Foundation |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | PCV7 + PPV23, 2 months, 6 months |
| Enrollment | 86 |
| Start date | May 1, 2002 |
| Primary completion | Jun 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 1, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: